E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines.
Douglas P. Zipes,A. John Camm,Martin Borggrefe,Alfred E. Buxton,Bernard R. Chaitman,Martin Fromer,Gabriel Gregoratos,George Klein,Arthur J. Moss,Robert J. Myerburg,Silvia G. Priori,Miguel A. Quinones,Dan M. Roden,Michael J. Silka,Cynthia M. Tracy,Jean Jacques Blanc,Andrzej Budaj,Veronica Dean,Jaap W. Deckers,Catherine Despres,Kenneth Dickstein,John Lekakis,Keith McGregor,Marco Metra,João Morais,Ady Osterspey,Juan Tamargo,José Luis Zamorano,Sidney C. Smith,Alice K. Jacobs,Cynthia D. Adams,Elliott M. Antman,Jeffrey L. Anderson,Sharon A. Hunt,Jonathan L. Halperin,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +38 more
TL;DR: The 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the revention of Sudden Cardiac Death focused on the treatment and prevention of sudden cardiac death.
Journal ArticleDOI
Hirudin in Acute Myocardial Infarction Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B Trial
TL;DR: Hemarin and hirudin have an equal effect as adjunctive therapy to TPA and streptokinase in preventing unsatisfactory outcome in patients with acute myocardial infarction.
Journal ArticleDOI
ACCF/ACG/AHA 2010 expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use
Neena S. Abraham,Mark A. Hlatky,Elliott M. Antman,Deepak L. Bhatt,David J. Bjorkman,Craig Clark,Curt D. Furberg,David A. Johnson,Charles J. Kahi,Loren Laine,Kenneth W. Mahaffey,Eamonn Martin Quigley,James M. Scheiman,Laurence S. Sperling,Gordon F. Tomaselli +14 more
TL;DR: The ACCCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines focused on reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use.
Journal ArticleDOI
Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction TIMI 11B–ESSENCE Meta-Analysis
Elliott M. Antman,Marc Cohen,David Radley,Carolyn H. McCabe,Janet Rush,Jerome Premmereur,Eugene Braunwald +6 more
TL;DR: Accumulated evidence indicates that enoxaparin should be considered as a replacement for unfractionated heparin as the antithrombin for the acute phase of management of patients with high-risk unstable angina/non-Q-wave myocardial infarction.
Journal ArticleDOI
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes
James A. de Lemos,David A. Morrow,David A. Morrow,Marc S. Sabatine,Marc S. Sabatine,Sabina A. Murphy,Sabina A. Murphy,C. Michael Gibson,C. Michael Gibson,Elliott M. Antman,Elliott M. Antman,Carolyn H. McCabe,Christopher P. Cannon,Christopher P. Cannon,Eugene Braunwald,Eugene Braunwald +15 more
TL;DR: In a large cohort of patients with acute coronary syndromes, an elevated baseline level of MCP-1 was associated both with traditional risk factors for atherosclerosis as well as an increased risk for death or myocardial infarction, independent of baseline variables.